| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |